Management Team
Martin A. Cannon
Director and Chief Executive Officer
Mr. Cannon has held senior positions with several leading management consulting firms including 15 years of experience at Bain & Company and A.T. Kearney, which acquired Cannon Associates, an international consulting and business development firm founded by Mr. Cannon. As a partner at Bain & Company, he concentrated on the diagnostic instrumentation (including ultrasound), blood banking and hospital management industries. Mr. Cannon also served as Executive Vice President with Commerce One, Inc., and Group President, Management Consulting with AppNet, Inc. with responsibility for the development and deployment of software-based decision support platforms. He is a graduate of Oxford University.
Barret W. Hildebrand
Vice President and Chief Financial Officer
Mr. Hildebrand serves as NHSi’s Chief Financial Officer. Previously, Mr. Hildebrand served as President and founder of Visiant, LLC, a management and technology consulting firm. Mr. Hildebrand has held consulting and management positions with Commerce One (formerly AppNet, Inc.), BSG Corporation, SHL Systemhouse, and McKinsey & Company. He earned a Master of Business Administration from George Washington University and a Bachelor of Science in Electrical Engineering from Lehigh University.
Tatsuro Yoshida
Director, Research and Development, Hemanext
Dr. Yoshida serves as Director, Research and Development for Hemanext and is one of the two co-inventors of the Hemanext technology. He specializes in red blood cell physiology and heme protein biochemistry.
Prior to joining New Health Sciences, Dr. Yoshida was Assistant Professor at Boston University’s Department of Biomechanical Engineering.
Dr. Yoshida earned a Ph.D. in Biophysics from the University of Michigan, and a B.A. in Physics & Biophysics from the University of Pennsylvania.
Dr. Tatjana Rundek, M.D., Ph.D., Consultant
Dr. Rundek is currently the Assistant Professor of Neurology at the University of Miami and also has a role at the Adjunct Research Faculty of the Department of Stroke and Critical Care at Columbia University. Dr. Rundek was formerly Assistant Professor of Neurology and Director of the Research Neurosonology Laboratory at Columbia University. She received her training at the University Hospital Sisters of Mercy in Zagreb, Croatia and at Brossharden Spital in Munich. Dr. Rundek is a member of the Editorial Board of Neurology, Stroke and the Journal of Cardio-Metabolic Syndrome and has over 80 publications.